Document is current
Any future updates will be listed below
-
Authors
Launay, Odile
Gupta, Rachna
Machabert, Tifany
Konate, Eleine
Rousseau, Alexandra https://orcid.org/0000-0002-9935-185X
Vigne, Claire https://orcid.org/0000-0003-3417-9814
Beckers, Francois https://orcid.org/0000-0003-3073-0832
Devlin, Louis
Botelho-Nevers, Elisabeth
Cachanado, Marine
Chidiac, Christian
Deplanque, Dominique
Dussol, Bertrand
Ben Ghezala, Inès
Lachatre, Marie
Lacombe, Karine https://orcid.org/0000-0001-8772-9029
Laine, Fabrice
Luong Nguyen, Liem Binh https://orcid.org/0000-0002-5235-0868
Pavese, Patricia
Schmidt-Mutter, Catherine https://orcid.org/0000-0002-8154-117X
Tavolacci, Marie-Pierre
Chicz, Roman M.
Coudsy, Bogdana
Sridhar, Saranya https://orcid.org/0000-0002-4267-3102
Touati, Amel
Tartour, Eric https://orcid.org/0000-0002-7323-468X
Simon, Tabassome
-
Funding
Funding for this research was provided by:
Sanofi
French Ministries of Solidarity and Health and of Higher Education, Research, and Innovation
- License Information
-
More Information
Article History
Received: 8 March 2023
Accepted: 12 November 2024
First Online: 18 January 2025
Competing interests
: The authors declare the following competing interests: R.G., T.M., C.V., F.B., L.D., R.M.C., B.C. and S.S. are Sanofi employees and may hold stocks/shares in the company. O.L. reports grant from French Ministry of Health and grants or contracts from Pfizer, Sanofi-Pasteur, GSK, MSD, MD, AstraZeneca, and Johnson & Johnson. T.S. reports grant from AstraZeneca, Novartis, Sanofi, Bayer and personal fees for board membership and consulting. K.L. reports personal fees and fees for development of educational presentations from Gilead, MSD, Janssen, ViiV, Spikimm, Janssen, Sobi, and Chiesi. EBN has received grant pending from Sanofi Pasteur and fees for board membership from Pfizer, and Janssen. L.B.L.N. received personal fees for advisory experts and participation to conference from Pfizer. All other authors have no competing interests to declare.
